Holen Sie sich die Stockscreener-App
61.53
4.77%
2.80
Handel nachbörslich:
61.53
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$58.73
Offen:
$58.83
24-Stunden-Volumen:
1.96M
Relative Volume:
0.86
Marktkapitalisierung:
$9.59B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
65.46
EPS:
0.94
Netto-Cashflow:
$245.03M
1W Leistung:
+3.62%
1M Leistung:
-3.04%
6M Leistung:
+31.87%
1J Leistung:
-13.40%
1-Tages-Spanne:
$58.42
$62.56
1-Wochen-Bereich:
$57.02
$62.56
52-Wochen-Spanne:
$46.01
$79.28
Bio Techne Corp Stock (TECH) Company Profile
Firmenname
Bio Techne Corp
Sektor
Branche
Telefon
612-379-8854
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Vergleichen Sie TECH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
61.53 | 9.15B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-07-09 | Eingeleitet | TD Cowen | Buy |
| 2025-05-30 | Eingeleitet | Wells Fargo | Overweight |
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-08 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-08-28 | Eingeleitet | William Blair | Outperform |
| 2023-01-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-25 | Bestätigt | The Benchmark Company | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-07-15 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-14 | Eingeleitet | The Benchmark Company | Buy |
| 2020-01-08 | Fortgesetzt | Stephens | Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-02 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-17 | Eingeleitet | Goldman | Neutral |
| 2018-06-15 | Eingeleitet | Argus | Buy |
| 2017-07-13 | Eingeleitet | Wells Fargo | Market Perform |
| 2017-02-09 | Eingeleitet | Citigroup | Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2013-09-20 | Hochstufung | Robert W. Baird | Neutral → Outperform |
Alle ansehen
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Creative Planning Has $4.29 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Envista, Alignment Healthcare, LifeStance Health Group, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know - Finviz
First Week of July 2026 Options Trading For Bio-Techne (TECH) - Nasdaq
Catalyst Funds Management Pty Ltd Boosts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Exclusive AI-Designed Protein Access Might Change the Case for Investing in Bio-Techne (TECH) - Yahoo! Finance Canada
Argus Research Maintains Bio-Techne (TECH) Buy Recommendation - Nasdaq
Bio-Techne Corp (TECH) Stock Forecasts - Yahoo! Finance Canada
Argus Research Maintains Buy Rating on Bio-Techne (TECH) with Pr - GuruFocus
Bio-Techne at Jefferies Conference: Strategic Insights and Innovations - Investing.com
Can Bio Techne Corporation (TE1) stock sustain breakout momentumForecast Cut & AI Forecast for Swing Trade Picks - newser.com
Will Bio Techne Corporation (TE1) stock boost dividends further2025 Breakouts & Breakdowns & Precise Buy Zone Tips - newser.com
Will Bio Techne Corporation stock split attract more investorsShare Buyback & Precise Trade Entry Recommendations - newser.com
How Bio Techne Corporation (TE1) stock benefits from digital adoption2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Can Bio Techne Corporation (TE1) stock deliver double digit returnsJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - newser.com
Rothschild Investment LLC Purchases 17,529 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corporation (TECH) stock price, news, quote and history - Yahoo Finance UK
Bio-Techne Corp $TECH Shares Sold by KBC Group NV - MarketBeat
Bio-Techne Corp $TECH Stock Holdings Lessened by PNC Financial Services Group Inc. - MarketBeat
How interest rate cuts could boost Bio Techne Corporation stockJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Will Bio Techne Corporation stock deliver strong dividend growthRisk Management & Weekly Setup with High ROI Potential - newser.com
Banco Bilbao Vizcaya Argentaria S.A. Has $427,000 Stock Position in Bio-Techne Corp $TECH - MarketBeat
Will Bio Techne Corporation (TE1) stock beat value stocksEarnings Beat & High Accuracy Swing Entry Alerts - newser.com
Why retail traders accumulate Bio Techne Corporation (TE1) stock2025 Valuation Update & Stepwise Entry and Exit Trade Signals - newser.com
Will Bio Techne Corporation (TE1) stock gain from green policiesWeekly Trade Report & AI Enhanced Market Trend Forecasts - newser.com
Bio-Techne at Stephens Conference: Strategies Amid Mixed Results - Investing.com
Bio-techne licenses AI-designed protein technology from Monod Bio By Investing.com - Investing.com Nigeria
Bio-Techne (TECH) Secures Exclusive Licensing Deal with Monod Bi - GuruFocus
Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio - Investing News Network
Bio-techne licenses AI-designed protein technology from Monod Bio - Investing.com
Bio-Techne announces licensing agreement with Monod Bio - TradingView
Bio-Techne (NASDAQ: TECH) gains exclusive rights to AI NovoBody Duo bispecific proteins - Stock Titan
Bio-Techne Corp $TECH Shares Acquired by Dorsey & Whitney Trust CO LLC - MarketBeat
Geode Capital Management LLC Sells 30,889 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
How resilient is Bio Techne Corporation stock in market downturnsProfit Target & Fast Moving Trade Plans - newser.com
Comparing Bio Techne Corporation in custom built stock radarsWeekly Gains Summary & Weekly Watchlist for Consistent Profits - newser.com
Bio-Techne Corp (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Aviva PLC - MarketBeat
Can trapped investors hope for a rebound in Bio Techne CorporationJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Technical Reactions to TECH Trends in Macro Strategies - news.stocktradersdaily.com
Bio-Techne Corp. stock outperforms competitors on strong trading day - MSN
Heatmap analysis for Bio Techne Corporation and competitorsJuly 2025 Breakouts & Verified High Yield Trade Plans - newser.com
Is Bio Techne Corporation (TE1) stock overpriced at current multiplesCEO Change & Reliable Price Action Trade Plans - newser.com
Bio-Techne Corp $TECH Shares Sold by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Resona Asset Management Co. Ltd. Reduces Holdings in Bio-Techne Corp $TECH - MarketBeat
TECH SEC FilingsBio-Techne Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Bio-Techne Stock: Is Wall Street Bullish or Bearish? - inkl
Finanzdaten der Bio Techne Corp-Aktie (TECH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):